Medicine Man Technologies, Inc.
SHWZ · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $172,448 | $159,379 | $108,420 | $24,001 |
| % Growth | 8.2% | 47% | 351.7% | – |
| Cost of Goods Sold | $96,424 | $74,349 | $59,067 | $17,226 |
| Gross Profit | $76,024 | $85,030 | $49,354 | $6,774 |
| % Margin | 44.1% | 53.4% | 45.5% | 28.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $70,933 | $6,723 | $38,945 | $29,677 |
| SG&A Expenses | $70,933 | $59,423 | $38,945 | $29,677 |
| Sales & Mktg Exp. | $0 | $52,700 | $0 | $0 |
| Other Operating Expenses | $1,802 | $8,011 | $0 | $0 |
| Operating Expenses | $72,735 | $67,434 | $38,945 | $29,677 |
| Operating Income | $3,289 | $12,855 | $10,409 | -$22,903 |
| % Margin | 1.9% | 8.1% | 9.6% | -95.4% |
| Other Income/Exp. Net | -$18,097 | -$16,424 | $8,506 | $2,587 |
| Pre-Tax Income | -$14,809 | -$3,570 | $18,915 | -$20,316 |
| Tax Expense | $19,741 | $14,898 | $4,396 | -$899 |
| Net Income | -$34,549 | -$18,468 | $14,519 | -$19,417 |
| % Margin | -20% | -11.6% | 13.4% | -80.9% |
| EPS | -0.26 | -0.49 | 0.17 | -0.47 |
| % Growth | 46.9% | -388.2% | 136.2% | – |
| EPS Diluted | -0.26 | -0.49 | -0.06 | -0.47 |
| Weighted Avg Shares Out | 64,535 | 53,637 | 43,339 | 41,217 |
| Weighted Avg Shares Out Dil | 64,535 | 53,637 | 43,339 | 41,217 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $32,069 | $30,140 | $7,014 | $41 |
| Depreciation & Amortization | $20,934 | $11,549 | $8,577 | $477 |
| EBITDA | $38,194 | $38,119 | $34,506 | -$19,798 |
| % Margin | 22.1% | 23.9% | 31.8% | -82.5% |